Advisor Resource Council Laboratory Corp Of America Holdings Transaction History

Advisor Resource Council

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$203.72 - $248.97 $111,638 - $136,435	-548 Reduced 29.65%	1,300 $0
Q3 2022 Oct 26, 2022	SELL	$204.81 - $262.19 $1.77 Million - $2.27 Million	-8,644 Reduced 82.39%	1,848 $379,000
Q2 2022 Jul 27, 2022	BUY	$213.86 - $277.87 $1.2 Million - $1.56 Million	5,616 Added 115.18%	10,492 $2.46 Million
Q1 2022 Apr 20, 2022	SELL	$259.82 - $298.18 $963,932 - $1.11 Million	-3,710 Reduced 43.21%	4,876 $1.29 Million
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $1.28 Million - $1.48 Million	4,721 Added 122.15%	8,586 $2.7 Million
Q3 2021 Nov 16, 2021	SELL	$274.82 - $308.34 $447,956 - $502,594	-1,630 Reduced 29.66%	3,865 $1.09 Million
Q2 2021 Aug 19, 2021	BUY	$251.87 - $278.14 $1 Million - $1.11 Million	3,979 Added 262.47%	5,495 $1.52 Million
Q2 2021 Aug 13, 2021	BUY	$251.87 - $278.14 $381,834 - $421,660	1,516 New	1,516 $418,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.